Evidence map›Paper›PMID 37905592›Full record

ReviewCNS neuroscience & therapeutics2024

Perspective from single-cell sequencing: Is inflammation in acute ischemic stroke beneficial or detrimental?

Xinpeng Deng, Ziliang Hu, Shengjun Zhou, Yiwen Wu, Menglin Fu, Chenhui Zhou, Jie Sun, Xiang Gao, Yi Huang

Open access · goldAbstract readReview
In one paragraph

Review in CNS neuroscience & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Xinpeng DengDepartment of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Ziliang HuDepartment of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Shengjun ZhouDepartment of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Yiwen WuDepartment of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Menglin FuSchool of Economics and Management, China University of Geosciences, Wuhan, China.
Chenhui ZhouDepartment of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Jie SunDepartment of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Xiang GaoDepartment of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Yi HuangDepartment of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.ORCID 0009-0002-7926-0587
Ningbo University · CNChina University of Geosciences · CN

Funding

Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province 2022E10026Medicine and Health Science and Technology Projects of Zhejiang Province 2022KY305Medicine and Health Science and Technology Projects of Zhejiang Province 2022KY322Natural Science Foundation of Ningbo 2022J211Natural Science Foundation of Ningbo 2022J213Natural Science Foundation of Ningbo 2023J019Ningbo Health Branding Subject Fund PPXK2018-04Ningbo Top Medical and Health Research Program 2022020304
6 · The paper itself

Abstract

backgroundAcute ischemic stroke (AIS) is a common cerebrovascular event associated with high incidence, disability, and poor prognosis. Studies have shown that various cell types, including microglia, astrocytes, oligodendrocytes, neurons, and neutrophils, play complex roles in the early stages of AIS and significantly affect its prognosis. Thus, a comprehensive understanding of the mechanisms of action of these cells will be beneficial for improving stroke prognosis. With the rapid development of single-cell sequencing technology, researchers have explored the pathophysiological mechanisms underlying AIS at the single-cell level.

methodWe systematically summarize the latest research on single-cell sequencing in AIS.

resultIn this review, we summarize the phenotypes and functions of microglia, astrocytes, oligodendrocytes, neurons, neutrophils, monocytes, and lymphocytes, as well as their respective subtypes, at different time points following AIS. In particular, we focused on the crosstalk between microglia and astrocytes, oligodendrocytes, and neurons. Our findings reveal diverse and sometimes opposing roles within the same cell type, with the possibility of interconversion between different subclusters.

conclusionThis review offers a pioneering exploration of the functions of various glial cells and cell subclusters after AIS, shedding light on their regulatory mechanisms that facilitate the transformation of detrimental cell subclusters towards those that are beneficial for improving the prognosis of AIS. This approach has the potential to advance the discovery of new specific targets and the development of drugs, thus representing a significant breakthrough in addressing the challenges in AIS treatment.

Indexed as

Brain IschemiaIschemic StrokeStrokeHumansInflammationPrognosisacute ischemic strokeastrocytesmicrogliasingle-cell RNA sequencing

Identifiers

PMID37905592
PMCPMC10805403
OpenAlexW4388033705

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.